Professional Documents
Culture Documents
Hedley 2010
Hedley 2010
INTRODUCTION
Re-use of this article is permitted in accordance with
the Terms and Conditions set out at http://wileyonline The accurate automated enumeration and identifica-
library.com/onlineopen#OnlineOpen_Terms tion of platelets (PLTs), white blood cells (WBCs), and
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56 45
46 B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION
nucleated red blood cells (NRBCs) is an important and The protocols and methodologies used in this eval-
often challenging aspect of the complete blood count uation were those of the International Committee for
(CBC). Confirmation of accuracy of any of these Standardization in Hematology (ICSH) and the Clini-
parameters is time-consuming, costly, and the delay cal Laboratory Standards Institute (CLSI) for reference
in reporting may have a negative impact on patient differential counts and the evaluation of instrument
management. The new Beckman Coulter UniCel methods (ISLH 1994; Richardson Jones et al., 1996;
DxH 800 Coulter Cellular Analysis System (DxH 800; Koepke et al., 2007).
Miami, FL, USA) complete blood cell counter com-
bines advanced hardware technology, innovative
MATERIALS AND METHODS
computer algorithms, impedance technology, flow cell
volume, conductivity, and five light scatter measure- Evaluation and validation of the DxH 800 cellular
ments to analyze PLTs, WBCs, and NRBCs. These analysis system (with software version 1.0.0) was car-
technologies integrate to define a new and more accu- ried out in our hospital laboratory, an 800-bed tertiary
rate ‘signature position’ occupied by NRBCs as well as care hospital with over 700 000 inpatient, outpatient,
to identify discrete WBC populations and common and emergency visits annually. The hospital provides
cellular interferences. This data analysis is performed services for a large region and includes specialized
as part of every routine CBC and WBC differential services such as critical care/trauma, cardiology,
without the need for additional reagent. neurology, cancer care, and transplant (solid and
Highly accurate automated WBC, PLT, and NRBC hematopoietic) medicine.
counts, especially in the presence of interference, has
a large impact in the operational efficiency of the
Specimens
hematology laboratory (Schwartz & Stansbury, 1954;
Fernandez et al., 2001; La Porta, Bowden & Barr, A total of 272 specimens (including morphologically
2002; Bourner, Dhaliwal & Sumner, 2005; Harrison normal and hematological abnormal specimens) were
et al., 2005; Segal et al., 2005; Bodey, 2009). The pres- analyzed. All samples were anticoagulated with
ence of interfering particles in automated blood cell K2EDTA and were spent routine hematology clinical
enumeration often triggers a ‘flag’ for manual review. samples. Samples were stored at room temperature
Although flags are helpful and results in film review, and tested within 8 h of collection. All samples were
this flagging is often not sensitive enough (resulting run initially on the LH 780 in the CDR mode (primary
in false negatives) or misidentifies other cellular types aspiration), followed by similar testing on the compar-
(resulting in false positives) (Brown et al., 2001; Chin- ator instrument (DxH 800). WBC, NRBC, and PLT
Yee et al., 2001, 2002; Keeney, Brown & Chin-Yee, counts were performed on the entire sample set using
2001; Muller et al., 2006; Ghys, Malfait & J, 2009). previously published FCM reference methods (Chin-
Inaccurate automated enumeration of any parameter Yee et al., 2001, 2002; Kaplan, Johnson & Wolfe,
involves the traditional labor-intensive process of 2001; Keeney, Brown & Chin-Yee, 2001). The sam-
manually inspecting and assessing a peripheral blood ples recruited for the study were specifically chosen so
film for each of these parameters. Therefore, technolo- that the analytical range of the DxH 800 was chal-
gies that refine automated cell counting so that flag- lenged. All samples were morphologically examined
ging rates are reduced (by increasing specificity and and only those found to have NRBCs, giant PLTs, or
sensitivity) to those samples which absolutely require PLT clumping on a blood film were considered truly
manual inspection have the potential to significantly positive for those abnormalities.
improve workload and turn around times. The goal of
this study was to evaluate the new Beckman Coulter
DxH 800
UniCel DxH 800 cellular analysis system centered
upon correlation of WBC, NRBC, and PLT enumera- The DxH 800 is a fully automated analyzer that pro-
tion when compared to a predicate analyzer, the vides a CBC, WBC differential, reticulocyte percentage
Coulter LH 780, and flow cytometry (FCM) refer- and number, and NRBC enumeration. Advanced signal
ence methods. to noise algorithms have been developed with the goal
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION 47
of improving the reportable range of this new number, as well as a NRBC percentage and number.
instrument (see Table 1), especially in the presence of The WBC count is derived by an impedance technol-
interference. The system comprises a data management ogy similar to that of the DxH 800. Classification of
module running on Microsoft Windows XP which WBCs is performed by threshold size discrimination
can store a database of up to 40 000 patient results with (>35 fl). Interfering particles such as NRBCs, nonlysed
graphical representation via a touch screen. Overall, red cells, giant PLTs, or PLT clumps, or fragmented
the DxH 800 cellular analysis system has a smaller foot- cells which hover near this threshold potentially may
print that the predicate LH 780 analyzer. A digital bar be included in the WBC count. If any interfering par-
code reader with 2D bar code capability is used for load- ticles are detected, the LH 780 generates a suspect
ing control materials and reagents which should help in message ‘cellular interference’ and will automatically
reducing errors in instrument setup and accurately correct the WBC count if necessary. Enumeration of
tracking reagent use. The capacity is twenty separate the NRBC count is performed when particles are
five-tube cassettes with a maximal automated through- detected in the NRBC signature positions of both the
put of 100 samples per hour. The aspiration volume in WBC and the differential plots.
both open/closed vial modes has been reduced to
165 ll of sample allowing for small volume samples to
Manual RBC indices correction
be run (e.g. pediatric samples). A new flow cell design
supports additional light scatter measurements enabling The standard laboratory method involved centrifuga-
enhanced data acquisition for the WBC differential, tion of the sample and preparation of a concentrated
reticulocyte, and NRBC analyses. This enhanced data red blood cell suspension, free of WBCs. The following
collection allows the DxH 800 to collect 10 times more calculations were applied; the corrected RBC count
information on each sample when compared to predi- was determined by subtraction of the WBC count
cate analyzers. These advances allow the DxH 800 to from the original RBC number of the neat sample. A
accurately determine a WBC count even in the pres- corrected Hct was determined by multiplying the true
ence of interference. A new feature on the DxH 800 is MCV, derived from the RBC suspension, by the cor-
the appropriate correction of RBC parameters in the rected RBC and dividing by 10. Finally, a corrected Hb
presence of leukocytosis [uncorrected (UWBC) was calculated by multiplying the true MCHC, derived
11 · 109/l]. Hemoglobin is corrected when the UWBC from the RBC suspension, by the corrected Hct.
count is 11 · 109/l and if the UWBC count is
140 · 109/l then the RBC count is automatically cor-
Daily operations
rected. The MCV, red cell distribution width (RDW),
and red cell distribution width standard deviation Daily checks were performed each day as part of rou-
(RDWSD) are corrected only if there is evidence that tine startup procedures. Startup was performed to
the WBC events are negatively impacting the RBC his- ensure that the fluidics lines were purged of cleaning
togram. The accuracy of the DxH 800 was determined agent, and that the background counts, voltage read-
by analyzing samples on a predicate analyzer (LH 780) ings, and reagent dates were within acceptable limits
and with a select group of parameters, by a flow cyto- prior to data collection. Quality Control on all instru-
metric reference method (FCM). Flagging rates were ments was run daily to ensure that all instruments
determined by comparing data from the DxH 800 and were operating within acceptable limits. Following
predicate LH 780 analyzer. daily operation, shutdown was performed ensuring
appropriate cleansing of the fluidic system.
LH 780
Coulter XL-MCL
The LH 780 is a fully automated random access ana-
lyzer with a throughput capability of 110 samples per The flow procedures were performed on a single laser
hour (CBC/DIFF only). The analyzer generates a CBC, four-color Beckman Coulter XL-MCL flow cytometer.
with a corrected WBC in the presence of interference, Alignment and calibration checks were performed
a WBC differential, a reticulocyte percentage and daily.
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
48 B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION 49
(a) (b)
Table 1. The range of linearity of the new DxH 800 cellular analysis system and the LH 780
WBC, white blood cell; PLT, platelet; NRBC, nucleated red blood cell.
Lines of best fit were generated for all the data to both the LH 780 (P = 0.762) and FCM (P = 0.693)
(Figure 1a) confirming that the new DxH 800 demon- with no significant bias in leukocyte count, with or
strates extremely good correlation with the predicate without the samples flagged for review removed
reference LH 780 analyzer and the reference FCM (Table 2).
(r2 = 0.998 and 0.994, respectively). Analysis of the A subset of the total number of samples (n = 46)
WBC counts for accuracy showed there was no signif- were flagged for cellular interference, caused by the
icant difference between the DxH 800 and the LH 780 presence of either giant PLTs, PLT clumping, or
or FCM (P = 0.918, ANOVA). The DxH 800 showed no NRBCs. The DxH 800 showed again high correlative
statistical difference between results when compared results with the LH 780 (r2 = 0.996) and FCM
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
50 B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION
Table 2. Accuracy P values, bias (mean difference), and % mean difference for the DxH 800 cellular analysis system vs. the
LH 780 and flow cytometry (FCM)
P value P value
Parameter Subset P value (w/o flags) Bias % Diff P value (w/o flags) Bias % Diff
WBC, white blood cell; PLT, platelet; NRBC, nucleated red blood cell.
Table 3. Evaluation of the DxH 800 automated RBC correction compared to manual RBC correction on high white
blood cell (WBC) counts
Red cell count Hemoglobin (g/l) Mean cell volume RDW (%)
(·1012/l) (fl)
WBC (·109/l) DxH Manual DxH Manual DxH Manual DxH Manual
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION 51
and RDW values are comparable by both methods set of samples containing microcytic or fragmented
with a slightly lower MCV noted by the manual RBCs (n = 28) were evaluated and again the DxH 800
method. analyzer demonstrated good correlation with the LH
780 and FCM data (Figure 2c) with r2 values of 0.998
and 0.966, respectively. Both of these PLT subsets
PLT
showed no significant difference between groups (ANO-
For this study, a FCM reference procedure was used VA, P = 0.514 and P = 0.903, respectively). PLT accu-
to accurately validate PLT counts from the newly racy data at <50, <20, <10 · 109/l PLTs are shown in
developed DxH 800 analyzer. Samples analyzed by Table 4 show an impressive performance, particularly
FCM were in the PLT range of 1 to 1297 · 109/l in the lower ranges. Of particular note, those samples
(n = 256). The DxH 800 showed a strong correlation
with both the LH 780 and the FCM (r2 = 0.996 and
Table 4. Platelet (PLT) sensitivity and specificity values
r2 = 0.985, respectively). The DxH 800 gave accurate
for the DxH 800 vs. flow cytometry
results when compared to both the LH 780 and the
FCM (P = 0.804, ANOVA) with a small, statistically PLT count Sensitivity Specificity False
insignificant negative bias (Table 2). The accuracy (·109/l) TP/(TP + FN) TN/(TN + FP) negative
improved when samples that were flagged for review
<10 92.3% 100% 1/13*
were excluded.
<20 83.3% 97.6% 5/30†
A subset of all the samples (n = 57) contained <50 96.6% 95.1% 2/58‡
megathrombocytes, a cellular characteristic that
potentially could influence the PLT count. The DxH *This single value has a value of 10.3.
800 showed strong correlation with both reference †All samples were flagged for review by the DxH 800.
‡These two samples only showed a small difference in
data sets again (LH 780 and FCM, Figure 2b) with r2
PLT count.
values of 0.996 and 0.974, respectively. A second sub-
(a) (b)
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
52 B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION
NRBC
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION 53
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
54 B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION
(<0.5 · 109/l). The DxH 800 does generate flags; how- on their proportions the machine may generate a
ever, the messages are more detailed than in previous ‘flag’. Generation of the flag requires verification by
analyzers and alert the operator to potential sample or another method (either manual chamber count or
enumeration issues. Manual review of these samples FCM), with the manual chamber count carrying a
may still be necessary, depending on laboratory pol- high coefficient of variation and FCM being impracti-
icy, in order that accurate results are communicated cal or unavailable for many laboratories. (Hanseler,
to the treating physician. Fehr & Keller, 1996; Harrison et al., 2000). The DxH
The heterogeneous morphology of NRBCs can lead 800 boasts a significant increase in the amount of
to significant problems when enumerating WBC with information (256 channels) collected on each sample.
impedance technology. The ISLH method for correc- This combined with advances in algorithms and infor-
tion is dependent on manual review of suspect sam- mation sharing between other modules (potential
ples identified by NRBC flagging on a cellular analysis interference detected in another parameter, e.g. micr-
system. The number of NRBCs are then enumerated, ocytic RBC) help to reduce flagging and better enu-
expressed as the number present per 100 WBCs, and merate PLTs at low levels. The accurate enumeration
the WBC count is subsequently adjusted mathemati- of low numbers of PLTs is important because throm-
cally. The assumption that all NRBCs have been bocytopenia may be a dose-limiting factor for cancer
included within the WBC count may or may not hold patients undergoing chemotherapy and also serves a
true. NRBCs smaller than the WBC threshold will not trigger for PLT transfusion therapy (Navarro et al.,
have been included in the WBC count, whereas those 1998).
greater than the threshold have the potential to have The CSLI and ISLH guidelines have established the
been. Manual correction for all the NRBCs seen by lower limit for detection of NRBCs to be 1 per 100
morphological review may lead to over correction of WBCs. We observed a small negative bias, ()0.6), in
the WBC count. The DxH 800 uses advanced algo- NRBC enumeration on the DxH 800 over the range
rithms and the collection of ten times more data than from 0 to 60 NRBCs compared to FCM (FCM). It
previous analyzers to determine the ‘signature posi- should be noted, however, that below 10 NRBCs the
tion’ without the need for a nuclear dye (increasing bias seen was very small. The ability to enumerate
cost) or rerunning (increasing turn around time) as NRBCs at the lower limit is now available on the new
with other commercially available analyzers. DxH 800, representing a significant improvement.
One of the most beneficial enhancements provided The DxH 800 represents an improvement to previ-
by the DxH 800, in our estimation, is the appropriate ous analyzers with an extended range for key parame-
correction of red cell parameters in the presence of ters, better sensitivity in the low range, as well as the
extreme leukocytosis. Automated and accurate correc- accurate detection and enumeration of NRBCs at
tion of RBC parameters will allow for more rapid turn counts >1/100 WBCs. The reduction in flagging rate
around times in patients with extreme leukocytosis, of the NRBC parameter should translate into reduced
forgoing the need for manual manipulation and the numbers of technically demanding and time-consum-
potential for introduction of error. ing blood film reviews. The automatic correction of
The data in this study demonstrate that both test RBC parameters in extreme leukocytosis eliminates
and comparator instruments (DxH 800 and LH 780, the need for operator intervention and should signifi-
respectively) provide accurate PLT results and in the cantly reduce the turn around time of severely abnor-
case of the DxH 800, when the counts are extremely mal results. These enhancements are afforded without
low (<10 · 109/l). A negative bias across the range of the requirement of rerunning the sample or additional
PLT values above 50 · 109/l explains the low P values reagents.
seen in Table 2. When PLTs in the critical range 0–
50 · 109/l were compared, there was no bias noted
ACKNOWLEDGEMENTS
between the FCM and DxH 800 values. Cellular debris
(and other substances) and large PLTs may be The authors thank Mr. Patrick O’Neil and Mrs.
included or excluded in the PLT count and depending Maritza Lavernia for their assistance with this study.
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION 55
REFERENCES at high risk for neutropenic complica- patients? Journal of Hospital Medicine
tions during chemotherapy for meta- 2, 5–12.
Aulesa C., Pastor I., Naranjo D., Piqueras static breast cancer with doxorubicin or Koepke J.A., Van Assendelft O.W.,
J. & Galimany R. (2003) Validation of pegylated liposomal doxorubicin: the Brindza L.J., Davis B., Fernandes B.,
the Coulter LH 750 in a hospital refer- development of a prediction model. Gewirtz A.S. & Rabinovitch A. (2007)
ence laboratory. Laboratory Hematology American Journal of Clinical Oncology Reference leukocyte (WBC) differential
9, 15–28. 31, 369–374. count (proportional) and evaluation of
Aulesa C., Pastor I., Naranjo D. & Galima- Fernandez T., Domack L.B., Montes D., instrumental methods; approved stan-
ny R. (2004) Application of receiver Pineiro R., Landrum E. & Vital E. dard, 2nd edn. Clinical and Laboratory
operating characteristics curve (ROC) (2001) Performance evaluation of the Standards Institute, Pennsylvania.
analysis when definitive and suspect coulter LH 750 hematology analyzer. La Porta A.D., Bowden A.S. & Barr S.
morphologic flags appear in the New Laboratory Hematology 7, 217–228. (2002) Impact of the coulter LH 750 on
Coulter LH 750 Analyzer. Laboratory Ghys T., Malfait R. & J V.A.N.d.B. (2009) productivity, turnaround time, and
Hematology 10, 14–23. Performance evaluation of the Sysmex work flow in a core laboratory. Labora-
Bodey G.P. (2009) The changing face of XS-1000i automated haematology ana- tory Hematology 8, 218–224.
febrile neutropenia-from monotherapy lyser. International Journal of Labora- Muller R., Mellors I., Johannessen B.,
to moulds to mucositis. Fever and neu- tory Hematology 31, 560–566. Aarsand A.K., Kiefer P., Hardy J.,
tropenia: the early years. Journal of Hanseler E., Fehr J. & Keller H. (1996) Kendall R. & Scott C.S. (2006) Euro-
Antimicrobial Chemotherapy 63(Suppl Estimation of the lower limits of man- pean multi-center evaluation of the
1), i3–i13. ual and automated platelet counting. Abbott Cell-Dyn sapphire hematology
Bourner G., Dhaliwal J. & Sumner J. American Journal of Clinical Pathology analyzer. Laboratory Hematology 12,
(2005) Performance evaluation of the 105, 782–787. 15–31.
latest fully automated hematology ana- Harrison P., Horton A., Grant D., Briggs Navarro J.T., Hernandez J.A., Ribera J.M.,
lyzers in a large, commercial laboratory C. & MacHin S. (2000) Immunoplatelet Sancho J.M., Oriol A., Pujol M., Milla
setting: a 4-way, side-by-side study. counting: a proposed new reference F. & Feliu E. (1998) Prophylactic plate-
Laboratory Hematology 11, 285–297. procedure. British Journal Haematology let transfusion threshold during therapy
Brown W., Kaplan S., Keeney M., John- 108, 228–235. for adult acute myeloid leukemia:
son K., Wolfe N. & Chin-Yee I. (2001) Harrison P., Segal H., Briggs C., Murphy 10,000/microL versus 20,000/microL.
Workflow improvement with random M. & Machin S. (2005) Impact of Haematologica 83, 998–1000.
access and enhanced flagging on the immunological platelet counting (by the Nevo S., Fuller A.K., Hartley E., Borinsky
New Coulter LH 750 Hematology Ana- platelet/RBC ratio) on haematological M.E. & Vogelsang G.B. (2007) Acute
lyzer. Laboratory Hematology 7, 229– practice. Cytometry. Part B, Clinical bleeding complications in patients after
235. Cytometry 67, 1–5. hematopoietic stem cell transplantation
Chin-Yee I., Keeney M., Johnson K., ISLH (1994) International Council for with prophylactic platelet transfusion
Brown W., Wolfe N. & Kaplan S. Standardization in Hematology. Guide- triggers of 10 x 10(9) and 20 x 10(9)
(2001) White blood cell flagging rates of lines for evaluation of blood cell analyz- per L. Transfusion 47, 801–812.
the coulter LH 750 analyzer compared ers including those used for differential Oka S., Muroi K., Mori M., Matsuyama
with the Coulter Gen•S Hematology leukocyte and reticulocyte counting and T., Fujiwara S., Oh I., Ono Y., Kikuchi
Analyzer. Laboratory Hematology 7, cell marker application. Clinical and S., Sato K., Ueda M., Toshima M.,
211–216. Laboratory Haematology, 16, 157–174. Ozaki K., Takatoku M., Nagai T. & Oza-
Chin-Yee I., Brown W., Johnson K., Kee- Kaplan S.S., Johnson K. & Wolfe N. wa K. (2007) Evaluation of platelet
ney M., Steele B., Wolfe N. & Kaplan S. (2001) Validation of low platelet counts transfusion thresholds in patients with
(2002) Identification and enumeration from coulter LH 750 and Coulter Gen•S acute myeloblastic leukemia receiving
of nucleated red blood cells on the Analyzers. Laboratory Hematology 7, induction chemotherapy. Internal Medi-
coulter LH 750. Laboratory Hematology 198–203. cine 46, 1669–1670.
8, 210–217. Keeney M., Brown W. & Chin-Yee I. Richardson Jones A., Cornbleet J., Hou-
Cosler L.E., Sivasubramaniam V., Agboola (2001) Platelet counts and flagging rates wen B., Van Hove L., Koepke J.A., Sim-
O., Crawford J., Dale D. & Lyman G.H. from the LH 750 hematology analyzer son E., Swaim W.R. & Van Assendelft
(2005) Effect of outpatient treatment of compared with the ICSH/ISLH platelet O.W. (1996) Performance goals for the
febrile neutropenia on the risk thresh- reference method and the Gen•S Hema- internal quality control of multichannel
old for the use of CSF in patients with tology Analyzer. Laboratory Hematology hematology analyzers; approved stan-
cancer treated with chemotherapy. 7, 204–210. dard. Clinical and Laboratory Standards
Value Health 8, 47–52. Kho A.N., Hui S., Kesterson J.G. & Institute, Pennsylvania.
Dranitsaris G., Rayson D., Vincent M., McDonald C.J. (2007) Which observa- Sagmeister M., Oec L. & Gmur J. (1999)
Chang J., Gelmon K., Sandor D. & tions from the complete blood cell A restrictive platelet transfusion pol-
Reardon G. (2008) Identifying patients count predict mortality for hospitalized icy allowing long-term support of
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56
56 B. D. HEDLEY ET AL. DXH 800 PERFORMANCE EVALUATION
outpatients with severe aplastic anemia. ing haematology analysers in severe prophylactic transfusion thresholds of
Blood 93, 3124–3126. thrombocytopenia and potential impact platelets in leukemia patients. Blood 92,
Schwartz S.O. & Stansbury F. (1954) Sig- on platelet transfusion. British Journal 2183–2184.
nificance of nucleated red blood cells in Haematology 128, 520–525. Stachon A., Sondermann N., Imohl M. &
periperal blood: analysis of 1,496 cases. Slichter S.J. (2007) Platelet transfusion Krieg M. (2002) Nucleated red blood
JAMA 154, 1339–1340. therapy. Hematology/oncology Clinics cells indicate high risk of in-hospital
Segal H.C., Briggs C., Kunka S., Casbard of North America 21, 697–729. mortality. Journal of Laboratory and
A., Harrison P., Machin S.J. & Murphy Springer W., von Ruecker A. & Dickerhoff Clinical Medicine 140, 407–412.
M.F. (2005) Accuracy of platelet count- R. (1998) Difficulties in determining
2010 Blackwell Publishing Ltd, Int. Jnl. Lab. Hem. 2011, 33, 45–56